The efficacy and safety of the new GLP-1 medicines continues to garner interest and will be discussed #ADA2024 Here is an updated safety-focused summary of the field and where it might be headed @DiabetesCareADA #T2D #obesity pic.twitter.com/rtEQYtHQG0 Daniel J Drucker (@DanielJDrucker) June 6, 2024 Investigational GLP-1 medicines in the clinic Late-stage investigational GLP-1 medicines for type 2 diabetes and obesity include new molecules like retatrutide and orforglipron, showing potential differentiation from semaglutide and tirzepatide through better tolerability, greater weight loss, Hb A 1c reduction, and targeted outcomes
Overall, GLP-1 RAs appear to be more efficacious than DPP4 inhibitors in people with type 2 diabetes in terms of improving glycaemic control and reducing body weight ( Yet another aspect to consider is the recurring theme of precision medicine
SattarNLeeMMYKristensenSLBranchKRHPratoDKhurmiSet alCardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Editorial: Cellular and molecular mechanisms of lung regeneration, repair, and fibrosis
Check with your healthcare provider before adding any supplement to your routine Check with your healthcare provider before adding any supplement to your routine If youre looking into GLP-1 supplements because youre taking a prescription and want to ensure proper nutrition, Kitchens offers the following advice: Eat enough protein (around 25 to 30 grams per meal) to preserve muscle mass
